Handa Pharmaceuticals (ROCO:6620) Net Change in Cash : NT$397.3 Mil (TTM As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Handa Pharmaceuticals Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Handa Pharmaceuticals's Net Change in Cash for the three months ended in Jun. 2024 was NT$9.8 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was NT$397.3 Mil.

Handa Pharmaceuticals Net Change in Cash Historical Data

The historical data trend for Handa Pharmaceuticals's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Handa Pharmaceuticals Net Change in Cash Chart

Handa Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

225.35

-130.37

-16.81

102.60

301.13

Handa Pharmaceuticals Quarterly Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Net Change in Cash	Get a 7-Day Free Trial															7.94	988.54	-759.55	158.46	9.81

Handa Pharmaceuticals Net Change in Cash Calculation

Handa Pharmaceuticals's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	668.36	+	-1664.5	+	1305.616	+	-8.342
	=	301.1

Handa Pharmaceuticals's Net Change in Cash for the quarter that ended in Jun. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 5.696 + 137.64 + -139.562 + 6.037

= 9.8

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$397.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Handa Pharmaceuticals Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Handa Pharmaceuticals's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Handa Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Handa Pharmaceuticals Inc (ROCO:6620) » Definitions » Net Change in Cash

Comparable Companies

ROCO:4105 TPE:1789 TPE:1707 ROCO:4114 TPE:3705 ROCO:6785 ROCO:6576 TPE:1720 TPE:4746 TPE:4119 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692

Traded in Other Exchanges

N/A

Address

Nanke 3rd Road, 3F-1,3F-2, No.23, Xinshi Dist, Tainan, TWN, 74147

Website

http://www.handapharma.com.tw

Handa Pharmaceuticals Inc is a Taiwan based specialty pharmaceutical company. It is engaged in the development of niche drug. The company focuses on the development of high barrier/patentable niche products.

Handa Pharmaceuticals Headlines

No Headlines